Colleagues, the following is FYI and does not necessarily reflect my own
opinion. I have no further knowledge of the topic. If you do not wish to
receive these posts, set your email filter to filter out any messages
coming from @nutritionucanlivewith.com and the program will remove
anything coming from me.
---------------------------------------------------------
Keywords: OSTEOPOROSIS, OSTEONECROSIS, JAW, ENDODONTICS, BISPHOSPHONATES
Source: Edelman PR, Chicago
Released: Wed 28-Sep-2005, 07:00 ET
http://www.newswise.com/articles/view/514901/?sc=dwhp
Critical Information for Patients About Possible Side Effect of
Bisphosphonates
Newswise — An article titled, “Bisphosphonate-associated Osteonecrosis
of the Jaws and Endodontic Treatment: Two Case Reports,” in the October
issue of the Journal of Endodontics (JOE), a publication of the American
Association of Endodontists (AAE), suggests patients using
bisphosphonates as part of their cancer treatment and for debilitating
bone diseases, such as osteoporosis and Paget’s disease, may be at risk
of experiencing a painful, disfiguring condition known as osteonecrosis
of the jaw, a disease that leads to the breakdown of the bone. The word
osteonecrosis literally means “death of bone” (osteo = bone, necrosis =
death).
Initial symptoms include burning, tingling or localized pain in the jaw,
and may lead to more serious complications, such as infections and
jawbone degeneration. Patients who think they may be experiencing
symptoms of osteonecrosis of the jaw should seek counsel from their
general physicians and oncologists, and inform their dentists,
endodontists and other dental professionals that they are undergoing
treatment with bisphophonates.
The latest generation of bisphosphonates includes: alendronate
(Fosamax®); pamidronate (Aredia®); and zoledronate (Zometa®).
Bisphosphonates help strengthen bone and prevent fractures in the hip,
spine and other skeletal regions by inhibiting bone loss.
The article indicates that at the same time bisphosphonates support the
buildup of bone in areas weakened by disease or as a side effect of
treatment, some patients taking bisphosphonates may experience the
opposite effect in the lower and upper jawbones. “Considering the large
number of patients around the world using bisphosphonates for prevention
or treatment of osteoporosis, dentists may be dealing with a significant
potential complication,” write the authors.
Written by Aaron P. Sarathy, D.M.D., Sidney L. Bourgeois, Jr., D.D.S.
and Gary G. Goodell, D.D.S., M.S., M.A., the article suggests that
problems in some patients using bisphosphonates may be triggered by a
dental procedure, such as a tooth extraction, or could occur spontaneously.
To prevent complications, the article suggests that those who take
bisphosphonates seek counsel from their medical and dental providers
before any elective dental procedures, and that any non-elective dental
work – especially extractions, which, the article notes appear to
“precipitate the majority of this condition” – be done before starting
bisphosphonate therapy. When dental work is required after starting
bisphosphonate therapy, patients, physicians and general dentists should
consult with appropriate dental specialists, including endodontists,
because non-surgical root canal treatment may be a safer alternative to
extraction.
“Bisphosphonates are important drugs that help manage the side effects
of cancer treatments, as well as bone loss in people who have
osteoporosis,” says JOE Editor Kenneth M. Hargreaves, D.D.S., Ph.D..
“But, as this article indicates, both healthcare professionals and
patients should be aware of the risks so together they can ensure
optimal dental treatment.”
American Association of Endodontists
The American Association of Endodontists, headquartered in Chicago,
represents more than 6,600 members worldwide, including approximately 95
percent of all eligible endodontists in the United States. The
Association, founded in 1943, is dedicated to excellence in the art and
science of endodontics and to the highest standard of patient care. The
Association inspires its members to pursue professional advancement and
personal fulfillment through education, research, advocacy, leadership,
communication and service. For more information, visit the AAE Web site
at http://www.aae.org.
Complete article and abstract available to the media by contacting
Krista Sabia or Craig Samuels at Edelman.
--
Kathrynne Holden, MS, RD < [log in to unmask] >
"Ask the Parkinson Dietitian" http://www.parkinson.org/
"Eat well, stay well with Parkinson's disease"
"Parkinson's disease: Guidelines for Medical Nutrition Therapy"
http://www.nutritionucanlivewith.com/
----------------------------------------------------------------
This message was sent through the Ageing in Europe
mailing list.
Please visit the homepage of the ESA Research Network
on Ageing in Europe at http://www.ageing-in-europe.de
----------------------------------------------------------------
|